A multidisciplinary review of nutrition considerations in the pediatric oncology population: A perspective from Children's Oncology Group

Nutrition in Clinical Practice

Volumn 20, Issue 4, 2005, Pages 377-393

  Ladas, Elena J ^a   Sacks, Nancy ^b   Meacham, Lillian ^c   Henry, Dave ^d   Enriquez, Lori ^b   Lowry, Genevieve ^e   Hawkes, Ria ^f   Dadd, Gaye ^g   Rogers, Paul ^h  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^e CHILDREN S HOSPITAL OF NEW YORK   (United States)

^f Division of Medical Oncology   (United States)

^g PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^h BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ANTHROPOMETRY; CACHEXIA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CARBOHYDRATE METABOLISM; CHILDHOOD CANCER; CLINICAL PRACTICE; DRUG DISPOSITION; ENTERIC FEEDING; HUMAN; LIPID METABOLISM; NUTRITIONAL ASSESSMENT; OBESITY; PROTEIN METABOLISM; REVIEW; RISK ASSESSMENT; SOCIAL PSYCHOLOGY; TUBE FEEDING; UNDERWEIGHT; UNSPECIFIED SIDE EFFECT; CHILD; CHILD NUTRITION; EVIDENCE BASED MEDICINE; METABOLISM; METHODOLOGY; NEOPLASM; NUTRITIONAL REQUIREMENT; NUTRITIONAL SUPPORT; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CACHEXIA; CHILD; CHILD NUTRITION PHYSIOLOGY; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS; NUTRITIONAL REQUIREMENTS; NUTRITIONAL SUPPORT; PRACTICE GUIDELINES; SURVIVAL ANALYSIS;

EID: 33644816992     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426505020004377     Document Type: Review

References (139)

1. Ladas E, Sacks N, Brophy P, Rodgers P. Standards of nutritional care in pediatric oncology: results from a nationwide survey on the standards of practice in pediatric oncology: a Children's Oncology Group Study. Pediatr Blood Cancer. 2005 May 30.
2. Coates TD, Rickard KA, Grosfeld JL, Weetman RM. Nutritional support of children with neoplastic diseases. Surg Clin North Am. 1986;66:1197-1212.
3. Donaldson SS, Wesley MN, DeWys WD, Suskind RM, Jaffe N, vanEys J. A study of the nutritional status of pediatric cancer patients. Am J Dis Child. 1981;135:1107-1112.
4. Mauer AM, Burgess JB, Donaldson SS, et al. Special nutritional needs of children with malignancies: a review. JPEN J Parenter Enteral Nutr. 1990;14:315-324.
5. Van Eys J. Malnutrition in children with cancer: incidence and consequence. Cancer. 1979;43(5 suppl):2030-2035.
6. Lobato-Mendizabal E, Ruiz-Arguelles GJ, Marin-Lopez A. Leukaemia and nutrition, I: malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standard-risk acute lymphoblastic leukaemia. Leuk Res. 1989;13:899-906.
7. Lobato-Mendizabal E, Lopez-Martinez B, Ruiz-Arguelles GJ. A critical review of the prognostic value of the nutritional status at diagnosis in the outcome of therapy of children with acute lymphoblastic leukemia. Rev Invest Clin. 2003;55:31-35.
8. Lange BJ, Gerbing RB, Feusner J, et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA. 2005;293:203-211.
9. Pietsch JB, Ford C. Children with cancer: measurements of nutritional status at diagnosis. Nutr Clin Pract. 2000;15:185-188.
10. Andrassy RJ, Chwals WJ. Nutritional support of the pediatric oncology patient. Nutrition. 1998;14:124-129.
11. Hays DM, Merritt RJ, White L, Ashley J, Siegel SE. Effect of total parenteral nutrition on marrow recovery during induction therapy for acute nonlymphocytic leukemia in childhood. Med Pediatr Oncol. 1983;11:134-140.
12. Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin. 2004;54:208-236.
13. Anderson PM, Ramsay NK, Shu XO, et al. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant. 1998;22:339-344.
14. Skubitz KM, Anderson PM. Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study. J Lab Clin Med. 1996;127:223-228.
15. American Academy of Pediatrics. Nutritional management of children with cancer. In: Heinman RE, ed. Pediatric Nutrition Handbook. Elk Grove Village, IL: American Academy of Pediatrics; 2004:709-717.
16. Sacks N, Ringwald-Smith K, Hale G. Nutritional support. In: Altaian A, ed. Supportive Care of Children with Cancer. Baltimore, MD: Johns Hopkins University Press; 2004:243-261.
17. Langer CJ, Hoffman JP, Ottery FD. Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia. Nutrition. 2001;17:S1-20.
18. Argiles JM, Lopez-Soriano FJ. The role of cytokines in cancer cachexia. Med Res Rev. 1999;19:223-248.
19. Argiles JM, Moore-Carrasco R, Fuster G, Busquets S, Lopez-Soriano FJ. Cancer cachexia: the molecular mechanisms. Int J Biochem Cell Biol. 2003;35:405-409.
20. Van Eys J. Nutrition and cancer: physiological interrelationships. Annu Rev Nutr. 1985;5:435-461.
21. Saarinen UM, Koskelo EK, Teppo AM, Siimes MA. Tumor necrosis factor in children with malignancies. Cancer Res. 1990; 50:592-595.
22. Theologides A. Anorexia-producing intermediary metabolites. Am J Clin Nutr. 1976;29:552-558.
23. Peacock JL, Inculet RI, Corsey R, et al. Resting energy expenditure and body cell mass alterations in noncachectic patients with sarcomas. Surgery. 1987;102:465-472.
24. Kien CL, Camitta BM. Close association of accelerated rates of whole body protein turnover (synthesis and breakdown) and energy expenditure in children with newly diagnosed acute lymphocytic leukemia. JPEN J Parenter Enteral Nutr. 1987;11: 129-134.
25. Stallings VA, Vaisman N, Chan HS, Weitzman SS, Hahn E, Pencharz PB. Energy metabolism in children with newly diagnosed acute lymphoblastic leukemia. Pediatr Res. 1989;26:154-157.
26. Delbecque-Boussard L, Gottrand F, Ategbo S, et al. Nutritional status of children with acute lymphoblastic leukemia: a longitudinal study. Am J Clin Nutr. 1997;65:95-100.
27. Duggan C, Bechard L, Donovan K, et al. Changes in resting energy expenditure among children undergoing allogeneic stem cell transplantation. Am J Clin Nutr. 2003;78:104-109.
28. Berchard L, Adiv O, Jaksic T, Duggan C. Nutritional supportive care. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:1285-1300.
29. Shils M, Shike M. Nutritional support of the cancer patient. In: Shils M, Olson J, Shike M, Ross C, eds. Modern Nutrition in Health and Disease. Baltimore, MD: Lippincott Williams & Wilkins; 1999:1297-1326.
30. Young VR. Energy metabolism and requirements in the cancer patient. Cancer Res. 1977;37:2336-2347.
31. Rickard K, Lopez A, Godshall BJ, Wetman R, Grosfeld J. Nutritional strategies for children with cancer. Nutrition Focus. 1991;6:1-10.
32. Waterlow JC. Classification and definition of protein-calorie malnutrition. BMJ. 1972;3:566-569.
33. Bessler S. Nutritional assessment. In: Samour PQ, Helm KK, Lang CE, eds. Handbook of Pediatric Nutrition. Gaithersburg, MD: Aspen Publishers; 1999:19-47.
34. Nevin-Folino N, Miller M. Enteral nutrition. In: Samour PQ, Helm KK, Lang CE, eds. Handbook of Pediatric Nutrition. Gaithersburg, MD: Aspen Publishers; 1999:513-549.
35. Aker S, Lenssen P. Nutritional support of patients with hematologic malignancies. In: Hoffman R, Benz Jr E, Shattil S, Furie B, Cohen H, Silberstein L, eds. Hematology Basic Principles and Practice. New York, NY: Churchill Livingstone; 1995:1473-1482.
36. Chumlea WC, Guo SS. Physical growth and development. In: Samour PQ, Helm KK, Lang CE, eds. Handbook of Pediatric Nutrition. Gaithersburg, MD: Aspen Publishers; 1999:3-15.
37. Mei Z, Grummer-Strawn LM, Pietrobelli A, Goulding A, Goran MI, Dietz WH. Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am J Clin Nutr. 2002;75: 978-985.
38. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000;314:1-27.
39. Barale K, Charuhas P. Oncology and marrow transplantation. In: Samour P, Helm K, Lang C, eds. Handbook of Pediatric Nutrition. Gaithersburg, MD: Aspen Publishers; 1999:465-491.
40. Havala T, Shronts E. Managing the complications associated with refeeding. Nutr Clin Pract. 1990;5:23-29.
41. Solomon SM, Kirby DF. The refeeding syndrome: a review. JPEN J Parenter Enteral Nutr. 1990;14:90-97.
42. Food and Nutrition Board Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: The National Academy Press; 2002.
43. Rickard KA, Kirksey A, Baehner RL, et al. Effectiveness of enteral and parenteral nutrition in the nutritional management of children with Wilms' tumors. Am J Clin Nutr. 1980;33:2622-2629.
44. Rickard KA, Baehner RL, Coates TD, Weetman RM, Provisor AJ, Grosfeld JL. Supportive nutritional intervention in pediatric cancer. Cancer Res 1982;42(Suppl):766S-773S.
45. Ladas E. The neutropenic diet: an examination of the evidence: ON-LINE Oncology Nutrition Dietetic Practice Group. 2002;10.
46. Moody K, Charlson ME, Finlay J. The neutropenic diet: what's the evidence? J Pediatr Hematol Oncol. 2002;24:717-721.
47. Aquino VM, Smyrl CB, Hagg R, McHard KM, Prestridge L, Sandler ES. Enteral nutritional support by gastrostomy tube in children with cancer. J Pediatr. 1995;127:58-62.
48. Bakish J, Hargrave D, Tariq N, Laperriere N, Rutka JT, Bouffet E. Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors. Cancer. 2003;98:1014-1020.
49. den Broeder E, Lippens RJ, van't Hof MA, et al. Effects of naso-gastric tube feeding on the nutritional status of children with cancer. Eur J Clin Nutr 1998;52:494-500.
50. Deswarte-Wallace J, Firouzbakhsh S, Finklestein JZ. Using research to change practice: enteral feedings for pediatric oncology patients. J Pediatr Oncol Nurs. 2001;18:217-223.
51. Mathew P, Bowman L, Williams R, et al. Complications and effectiveness of gastrostomy feedings in pediatric cancer patients. J Pediatr Hematol Oncol 1996;18:81-85.
52. Han-Markey T. Nutritional considerations in pediatric oncology. Semin Oncol Nurs. 2000;16:146-151.
53. Pietsch JB, Ford C, Whitlock JA. Nasogastric tube feedings in children with high-risk cancer: a pilot study. J Pediatr Hematol Oncol. 1999;21:111-114.
54. Ringwald-Smith K, Krance R, Stricklin L. Enteral nutrition support in a child after bone marrow transplantation. Nutr Clin Pract. 1995;10:140-143.
55. Aitken TJ. Gastrointestinal manifestations in the child with cancer. J Pediatr Oncol Nurs. 1992;9:99-109.
56. Pronsky ZM. Food-Medication Interactions. 11th ed. Birchrunville, PA: Food-Medication Interactions; 2000.
57. A.S.P.E.N. Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002;26(Suppl):1SA- 138SA.
58. Pencharz PB. Aggressive oral, enteral or parenteral nutrition: prescriptive decisions in children with cancer. Int J Cancer Suppl. 1998;11:73-75.
59. Rohrer T, Trachsel D, Engelcke G, Hammer J. Congenital central hypoventilation syndrome associated with Hirschsprung's disease and neuroblastoma: case of multiple neurocristopathies. Pediatr Pulmonol. 2002;33:71-76.
60. Schlatter M, Snyder K, Freyer D. Successful nonoperative management of typhlitis in pediatric oncology patients. J Pediatr Surg. 2002;37:1151-1155.
61. Weiser AC, Lindgren BW, Ritchey ML, Franco I. Chylous ascites following surgical treatment for Wilms tumor. J Urol. 2003;170: 1667-1669.
62. Vanderhoof J, Young R. Overview of considerations for the pediatric patient receiving home parenteral and enteral nutrition. Nutr Clin Pract. 2003;18:221-226.
63. Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004;28: S39-S70.
64. Stettler N, Sentongo T, Carroll M, Schears G, Mascarenhas M. Impact of customized parenteral nutrition in a pediatric hospital. Nutr Clin Pract. 2001;16:345-348.
65. Ireton-Jones C, DeLegge M, Epperson L, Alexander J. Management of the home parenteral nutrition patient. Nutr Clin Pract. 2003;18:310-317.
66. Padilla GV, Grant MM. Psychosocial aspects of artificial feeding. Cancer. 1985;55(1 suppl):301-304.
67. Mermel LA, Fair BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249-1272.
68. Christensen ML, Hancock ML, Gattuso J, et al. Parenteral nutrition associated with increased infection rate in children with cancer. Cancer. 1993;72:2732-2738.
69. McCullers JA, Vargas SL, Flynn PM, Razzouk BI, Shenep JL. Candidal meningitis in children with cancer. Clin Infect Dis. 2000;31:451-457.
70. Dunn R, Stettler N, Mascarenhas M. Refeeding syndrome in hospitalized pediatric patients. Nutr Clin Pract. 2003;18:327-332.
71. Trauner M, Fickert P, Stauber RE. Inflammation-induced cholestasis. J Gastroenterol Hepatol. 1999;14:946-959.
72. Suita S, Ikeda K, Nagasaki A, et al. Follow-up studies of children treated with a long-term intravenous nutrition (PVN) during the neonatal period. J Pediatr Surg. 1982;17:37-42.
73. Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications of total parenteral nutrition. Gastroenterology. 1993;104:286-301.
74. Rickard KA, Detamore CM, Coates TD, et al. Effect of nutrition staging on treatment delays and outcome in stage IV neuroblastoma. Cancer. 1983;52:587-598.
75. Rickard KA, Coates TD, Grosfeld JL, Weetman RM, Baehner RL. The value of nutrition support in children with cancer. Cancer. 1986;58(8 suppl):1904-1910.
76. Van Eys J, Cangir A, Carter P, Coody D. Effect of nutritional supportive therapy on children with advanced cancer. Cancer Res 1982;42(Suppl):713S- 714S.
77. Donaldson SS, Wesley MN, Ghavimi F, Shils ME, Suskind RM, DeWys WD. A prospective randomized clinical trial of total parenteral nutrition in children with cancer. Med Pediatr Oncol. 1982;10:129-139.
78. Weisdorf S, Hofland C, Sharp HL, et al. Total parenteral nutrition in bone marrow transplantation: a clinical evaluation. J Pediatr Gastroenterol Nutr. 1984;3:95-100.
79. Weisdorf SA, Lysne J, Wind D, et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation. 1987;43:833-838.
80. Copeland EM III, Daly JM, Ota DM, Dudrick SJ. Nutrition, cancer, and intravenous hyperalimentation. Cancer. 1979;43(5 suppl):2108-2116.
81. Lenssen P, Bruemmer BA, Bowden RA, Gooley T, Aker SN, Mattson D. Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation. Am J Clin Nutr. 1998;67:927-933.
82. O'Neill JB, Cleaveland MJ, Forte K, et al. Scope and Standards of Pediatric Oncology Nursing Practice: Association of Pediatric Oncology Nurses/American Nursing Association. Washington, DC: American Nurses Publishing; 2000.
83. Christensen J, Akcasu N. The role of the pediatric nurse practitioner in the comprehensive management of pediatric oncology patients in the inpatient setting. J Pediatr Oncol Nurs. 1999;16: 58-65.
84. Lin SX, Gebbie KM, Fullilove RE, Arons RR. Do nurse practitioners make a difference in provision of health counseling in hospital outpatient departments? J Am Acad Nurse Pract. 2004; 16:462-466.
85. Bryant R. Managing side effects of childhood cancer treatment. J Pediatr Nurs. 2003;18:113-125.
86. Bowman IC, Williams R, Sanders M, Ringwald-Smith K, Baker D, Gajjar A. Algorithm for nutritional support: experience of the metabolic and infusion support service of St. Jude Children's Research Hospital. Int J Cancer. 1998;11:76-80.
87. Williams R, Hinds PS, Ke W, Hu XJ. A comparison of calorie and protein intake in hospitalized pediatric oncology patients dining with a caregiver versus patients dining alone: a randomized, prospective clinical trial. J Pediatr Oncol Nurs. 2004;21:223-232.
88. Wohlschlaeger A. Prevention and treatment of mucositis: a guide for nurses. J Pediatr Oncol Nurs. 2004;21:281-287.
89. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157-1167.
90. Carr R, Ensom M. Drug disposition and therapy in adolescence. J Pediatr Pharmacol Ther. 2003;8:86-96.
91. Krishnaswamy K. Drug metabolism and pharmacokinetics in malnourished children. Clin Pharmacokinet 1989;17(suppl 1):68-88.
92. Murry DJ, Riva L, Poplack DG. Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl. 1998; 11:48-51.
93. Anderson KE. Influences of diet and nutrition on clinical pharmacokinetics. Clin Pharmacokinet. 1988;14:325-346.
94. Lee JH, Suh OK, Lee MG. Pharmacokinetic changes in drugs during protein-calorie malnutrition: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes. Arch Pharm Res. 2004;27:693-712.
95. Vagenakis AG, Portnay GI, O'Brian JT, et al. Effect of starvation on the production and metabolism of thyroxine and triiodothyronine in euthyroid obese patients. J Clin Endocrinol Metab. 1977;45:1305-1309.
96. Homeida M, Karrar ZA, Roberts CJ. Drug metabolism in malnourished children: a study with antipyrine. Arch Dis Child. 1979;54:299-302.
97. Tranvouez JL, Lerebours E, Chretien P, Fouin-Fortunet H, Colin R. Hepatic antipyrine metabolism in malnourished patients: influence of the type of malnutrition and course after nutritional rehabilitation. Am J Clin Nutr. 1985;41:1257-1264.
98. Hamberg O, Ovesen L, Dorfeldt A, Loft S, Sonne J. The effect of dietary energy and protein deficiency on drug metabolism. Eur J Clin Pharmacol. 1990;38:567-570.
99. Cusack BJ, Young SP, Loseke VL, Hurty MR, Beals L, Olson RD. Effect of a low-protein diet on doxorubicin pharmacokinetics in the rabbit. Cancer Chemother Pharmacol. 1992;30: 145-148.
100. Davis LE, Lenkinski RE, Shinkwin MA, Kressel HY, Daly JM. The effect of dietary protein depletion on hepatic 5-fluorouracil metabolism. Cancer. 1993;72:3715-3722.
101. Kim YG, Cho MK, Kwon JW, Kim SG, Lee MG. Effects of cysteine on the pharmacokinetics of intravenous adriamycin in rats with protein-calorie malnutrition. Res Commun Mol Pathol Pharmacol. 2000;107:361-376.
102. Bolme P, Eriksson M, Paalzow L, Stintzing G, Zerihun G, Woldemariam T. Malnutrition and pharmacokinetics of penicillin in Ethiopian children. Pharmacol Toxicol. 1995;76: 259-262.
103. Mihranian MH, Wang YM, Daly JM. Effects of nutritional depletion and repletion on plasma methotrexate pharmacokinetics. Cancer. 1984;54:2268-2271.
104. Dunki Jacobs PB, Ruevekamp M, Varossiau FJ, Hart GA, de Graaf PW. Alterations in serum levels, anti-tumor activity and toxicity of methotrexate in rats after a short period of nutritional depletion. Eur J Cancer Clin Oncol. 1989;25:415-422.
105. Reynolds HM Jr, Daly JM, Rowlands BJ, Dudrick SJ, Copeland EM III. Effects of nutritional repletion on host and tumor response to chemotherapy. Cancer 1980;45:3069-3074.
106. Obama M, Cangir A, Van Eys J. Nutritional status and anthracycline cardiotoxicity in children. South Med J. 1983;76:577-578.
107. Charland SL, Bartlett D, Torosian MH. Effect of protein-calorie malnutrition on methotrexate pharmacokinetics. JPEN J Parenter Enteral Nutr. 1994;18:45-49.
108. Blouin RA, Warren GW. Pharmacokinetic considerations in obesity. J Pharm Sci. 1999;88:1-7.
109. Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet. 2000;39:215-231.
110. Rodvold KA, Rushing DA, Tewksbury DA. Doxorubicin clearance in the obese. J Clin Oncol. 1988;6:1321-1327.
111. Dunn TE, Ludwig EA, Slaughter RL, Camara DS, Jusko WJ. Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity. Clin Pharmacol Ther. 1991;49:536-549.
112. Zuccaro P, Guandalini S, Pacifici R, et al. Fat body mass and pharmacokinetics of oral 6-mercaptopurine in children with acute lymphoblastic leukemia. Ther Drug Monit. 1991;13:37-41.
113. Bastarrachea J, Hortobagyi GN, Smith TL, Kau SW, Buzdar AU. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med. 1994;120:18-25.
114. Georgiadis MS, Steinberg SM, Hankins LA, Ihde DC, Johnson BE. Obesity and therapy-related toxicity in patients treated for small-cell lung cancer. J Natl Cancer Inst. 1995; 87:361-366.
115. Meyerhardt JA, Catalano PJ, Haller DG, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer. 2003;98:484-495.
116. Meyerhardt JA, Tepper JE, Niedzwiecki D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol. 2004;22:648-657.
117. Evans AM. Influence of dietary components on the gastrointestinal metabolism and transport of drugs. Ther Drug Monit. 2000;22:131-136.
118. Vaisman N, Stallings VA, Chan H, Weitzman SS, Clarke R, Pencharz PB. Effect of chemotherapy on the energy and protein metabolism of children near the end of treatment for acute lymphoblastic leukemia. Am J Clin Nutr. 1993;57:679-684.
119. Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004;351:2590-2598.
120. Oberbaum M, Yaniv I, Ben Gal Y, et al. A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer. 2001;92:684-690.
121. Schmidt S, Petersen C, Bullinger M. Coping with chronic disease from the perspective of children and adolescents: a conceptual framework and its implications for participation. Child Care Health Dev. 2003;29:63-75.
122. Kusch M, Labouvie H, Ladisch V, Fleischhack G, Bode U. Structuring psychosocial care in pediatric oncology. Patient Educ Couns. 2000;40:231-245.
123. Brunnquell D, Hall MD. Issues in the psychological care of pediatric oncology patients. Am J Orthopsychiatry. 1982;52:32-44.
124. Children's Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers, version 1.2 [Children's Oncology Group website]. Available at: http://www.childrensoncologygroup.org. Accessed March, 2004.
125. Zee P, Chen CH. Prevalence of obesity in children after therapy for acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol. 1986;8:294-299.
126. Dalton VK, Rue M, Silverman LB, et al. Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment. J Clin Oncol. 2003;21:2953-2960.
127. Oeffinger KC, Mertens AC, Sklar CA, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2003; 21:1359-1365.
128. Sklar CA, Mertens AC, Walter A, et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol. 2000;35:91-95.
129. Nysom K, Holm K, Michaelsen KF, Hertz H, Muller J, Molgaard C. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab. 1999;84:4591-4596.
130. Didi M, Didcock E, Davies HA, Ogilvy-Stuart AL, Wales JK, Shalet SM. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. J Pediatr. 1995;127:63-67.
131. Schell MJ, Ochs JJ, Schriock EA, Carter M. A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 1992;10: 128-133.
132. Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003; 97:663-673.
133. Lustig RH, Post SR, Srivannaboon K, et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab. 2003;88:611-616.
134. Heikens J, Ubbink MC, van der Pal HP, et al. Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease. Cancer. 2000;88:2116-2121.
135. Ilveskoski I, Saarinen UM, Wiklund T, et al. Growth impairment and growth hormone therapy in children treated for malignant brain tumours. Eur J Pediatr. 1997;156:764-769.
136. Meacham LR, Gurney JG, Mertens AC, et al. Body mass index in long-term adult survivors of childhood cancer: a report of the childhood cancer survivor study (CCSS). Cancer. 2005;103:1730-1739.
137. Heimendinger J, Van Duyn MA, Chapelsky D, Foerster S, Stables G. The national 5 A Day for Better Health Program: a large-scale nutrition intervention. J Public Health Manag Pract. 1996;2:27-35.
138. Levin S, Martin MW, Riner WF. TV viewing habits and body mass index among South Carolina Head Start children. Ethn Dis. 2004;14:336-339.
139. Dietz WH, Gortmaker SL. Preventing obesity in children and adolescents. Annu Rev Public Health. 2001;22:337-353.